http://www.law360.com/ Latest articles for organization: Kaplan Fox Copyright 2009 Portfolio Media, Inc. en-US http://www.law360.com/images/headings/logo.gif http://www.law360.com/ http://www.law360.com/articles/134839 A federal judge has partially lifted a discovery stay in a securities suit against Bank of America Corp. over its merger with Merrill Lynch & Co. Inc., providing the plaintiffs with access to the same documents the bank has already shown to several government agencies. http://www.law360.com/articles/134839 http://www.law360.com/articles/129960 A $336 million settlement a class of consumers reached with credit card companies and banks accused of breaching federal and state antitrust laws by colluding to fix foreign currency fees has been granted approval by a federal judge, three years after the defendants put the money away in escrow to repay the plaintiffs. http://www.law360.com/articles/129960 http://www.law360.com/articles/124967 Direct purchaser plaintiffs in an antitrust class action alleging Biovail Corp. and GlaxoSmithKline PLC conspired to stifle the market for a generic version of antidepressant Wellbutrin XL have asked defendants to turn over market projections depicting how the generic would affect sales and prices for the branded bupropion. http://www.law360.com/articles/124967 http://www.law360.com/articles/124908 A group of pension funds appointed as lead plaintiff in multidistrict securities litigation against Bank of America Corp. has filed an amended complaint accusing the bank of suppressing billions of dollars in losses that Merrill Lynch & Co. Inc. suffered before the financial giants finalized their $50 billion union. http://www.law360.com/articles/124908 http://www.law360.com/articles/124772 Plaintiffs are seeking to obtain class status in a multidistrict litigation accusing Pfizer Inc. and its Warner-Lambert Co. subsidiary of using patent litigation to postpone generic competition for epilepsy treatment Neurontin. http://www.law360.com/articles/124772 http://www.law360.com/articles/124794 A federal judge has granted final approval for an $85 million settlement, including more than $14.3 million in attorneys' fees and expenses, between Lufthansa AG and plaintiffs in the massive multidistrict litigation that accused a host of air cargo shipping service companies of a worldwide price-fixing scheme. http://www.law360.com/articles/124794 http://www.law360.com/articles/122788 Plaintiffs in a price-fixing suit against plastic additives makers have once again moved for class certification in the wake of a federal appeals court decision that revoked their class status the first time around. http://www.law360.com/articles/122788 http://www.law360.com/articles/121652 Abbott Laboratories has asked a judge to throw out four recently amended complaints filed by pharmacies, wholesale direct drug purchasers and rival drug manufacturers alleging Abbott illegally jacked up the prices of its market-dominating HIV drugs, calling the complaints “a vain attempt to plead around” recent antitrust case law. http://www.law360.com/articles/121652 http://www.law360.com/articles/120059 Abrika Pharmaceuticals Inc. has asked the court in charge of antitrust litigation against Biovail Corp. and GlaxoSmithKline PLC over the antidepressant Wellbutrin XL to let it intervene in the case to fight the direct purchaser plaintiffs' bid for documents from patent litigation Biovail brought against Abrika in Florida. http://www.law360.com/articles/120059 http://www.law360.com/articles/119630 A federal judge has refused to overturn a jury verdict and grant Louisiana Wholesale Drug Co. Inc. a new trial in an antitrust class action filed by the drug wholesaler accusing Sanofi-Aventis U.S. LLC of submitting a sham citizen petition to delay release of generic versions of an arthritis drug. http://www.law360.com/articles/119630 http://www.law360.com/articles/119373 A federal judge has cleared the way for the multidistrict litigation alleging Pfizer Inc. and its Warner-Lambert Co. subsidiary engaged in a scheme to use patent litigation to delay generic competition for the epilepsy drug Neurontin to move forward. http://www.law360.com/articles/119373 http://www.law360.com/articles/118128 Citing Twombly, a federal judge overseeing multidistrict antitrust litigation against a group of major airlines has kept alive the action's Sherman Act claims despite a magistrate judge's recommendation that they be tossed, saying the plaintiffs established plausible grounds to allege an agreement among the carriers to fix air cargo prices. http://www.law360.com/articles/118128 http://www.law360.com/articles/115816 Northern Trust Securities Inc. has won the dismissal of a putative class action accusing the financial holding company of failing to alert investors of the risks associated with auction rate securities. http://www.law360.com/articles/115816 http://www.law360.com/articles/115698 The lead plaintiffs in a suit accusing an Arizona health care association and some member hospitals of operating an anti-competitive cartel to drive down nurses' wages have asked the court to rethink its decision to exclude traveling nurses from the class. http://www.law360.com/articles/115698 http://www.law360.com/articles/114476 Electronic component manufacturer International Rectifier Corp. has agreed to shell out $90 million to settle an investor class action alleging the company reported inflated financial results to investors over a five-year period. http://www.law360.com/articles/114476 http://www.law360.com/articles/114239 A federal judge overseeing securities litigation stemming from Bank of America Corp.'s $50 billion acquisition of Merrill Lynch & Co. has denied a bid to seek appeal of an order granting lead plaintiff status to a group of five public pension funds. http://www.law360.com/articles/114239 http://www.law360.com/articles/112983 Bristol-Myers Squibb Co. has reported a $125 million settlement in a securities class action that accuses the drugmaker of duping shareholders and causing a stock drop when it failed to properly disclose a patent deal for a generic version of its blood-thinning drug Plavix. http://www.law360.com/articles/112983 http://www.law360.com/articles/112277 Solvay Pharmaceuticals Inc. and Watson Pharmaceuticals Inc. are aiming to throw out the Federal Trade Commission’s suit that alleges patent settlements over the testosterone supplement AndroGel restrained competition, arguing that the settlements are legal under an appeals court’s precedent. http://www.law360.com/articles/112277 http://www.law360.com/articles/111394 A group of nurses has won class certification in a suit accusing an Arizona health care association and some member hospitals of operating an anti-competitive cartel to drive down nurses' wages. http://www.law360.com/articles/111394 http://www.law360.com/articles/109496 A federal judge has divided 30 pending cases accusing Bank of America Corp. of misleading investors into signing off on its $50 billion acquisition of Merrill Lynch & Co. into three major groups — securities, derivatives and 401(k) plan claimants — and picked interim leads for the putative classes. http://www.law360.com/articles/109496